CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Peginterferon alfa-2a Injection
FDA source answer
FDA source rows are resolved or no longer current.
FDA source statuses: Resolved. First FDA posting: 2025-01-24. Latest FDA row update: 2026-08-27.
FDA lists 2 package records, with companies: pharmaand GmbH, pharmaand GmbH (pharma&). Package NDCs: 82154-0449-1, 82154-0451-4.
FDA shortage reason: Not stated in the grouped FDA source rows.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| pharmaand GmbH (pharma&) | 82154-0451-4 | Pegasys, Injection, 180 ug/.5 mL (NDC 82154-0451-4) | Not stated | 2026-08-27 |
| pharmaand GmbH (pharma&) | 82154-0449-1 | Pegasys, Injection, 180 ug/1 mL (NDC 82154-0449-1) | Not stated | 2026-08-27 |
Source facts
Grouped generic ingredient: Peginterferon alfa-2a Injection · 2 package records
Therapeutic categories: Antiviral
Dosage forms: Injection
Routes: SUBCUTANEOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.